Biopharma News

May 16, 2018
By BioPharm International Editors
Valerius Biopharma will use Catalent’s GPEx technology to produce cell lines for biosimilar drugs.
May 16, 2018
By BioPharm International Editors
The acquisition is expected to strengthen Novartis’ gene therapy pipeline.
May 16, 2018
By BioPharm International Editors
The agency has approved Retacrit (epoetin alfa-epbx) by Pfizer’s Hospira, which is a biosimilar to Amgen’s anemia drug, Epogen/Procrit (epoetin alfa).
May 15, 2018
By BioPharm International Editors
Eli Lilly will acquire ARMO BioSciences to strengthen Lilly's immuno-oncology program.
May 14, 2018
By BioPharm International Editors
Barriers impede biosimilar market entry into the United States despite the Biologics Price Competition and Innovation Act.
May 11, 2018
The use of more targeted therapies is expanding as the public gains access to low-cost genetic testing, and more advanced computer systems are offering data from healthcare systems.
May 09, 2018
By BioPharm International Editors
Takeda expands its global and therapy base with announced acquisition of Shire.
May 09, 2018
By BioPharm International Editors
Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.
May 09, 2018
By BioPharm International Editors
The companies expanded their partnership to develop and commercialize messenger RNA (mRNA) cancer vaccines to include shared-antigen mRNA cancer vaccines such as mRNA-5671.
May 08, 2018
By BioPharm International Editors
The company received a complete response letter from FDA in response to the biologics license application for a proposed rituximab biosimilar.
native1_300x100
lorem ipsum